Antagonists of cb1 receptor

作者: Luigi Bellocchio , Pier Vincenzo Piazza , Monique Vallee , Sergio Vitiello , Giovanni Marsicano

DOI:

关键词:

摘要: The invention relates to an antagonist of CB1 receptor for use in the treatment a pathologic condition or disorder selected from group consisting bladder and gastrointestinal disorders; inflammatory diseases; cardiovascular nephropathies; glaucoma; spasticity; cancer; osteoporosis; metabolic obesity; addiction, dependence, abuse relapse related psychiatric neurological neurodegenerative autoimmune hepatitis encephalitis; pain; reproductive disorders skin fibrotic diseases.

参考文章(113)
Vincent J. Aloyo, Kelly A. Berg, William P. Clarke, Umberto Spampinato, John A. Harvey, Inverse agonism at serotonin and cannabinoid receptors. Progress in Molecular Biology and Translational Science. ,vol. 91, pp. 1- 40 ,(2010) , 10.1016/S1877-1173(10)91001-6
Rupal Pandey, Venkatesh L Hegde, Narendra P Singh, Lorne Hofseth, Uday Singh, Swapan Ray, Mitzi Nagarkatti, Prakash S Nagarkatti, None, Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis. Vitamins and Hormones Series. ,vol. 81, pp. 487- 504 ,(2009) , 10.1016/S0083-6729(09)81019-4
David L. Berliner, Nathan W. Adams, Clive L. Jennings-White, Louis Monti, 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS ,(2002)
M. A. Cosenza-Nashat, A. Bauman, M.-L. Zhao, S. Morgello, H.-S. Suh, S. C. Lee, Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities. Neuropathology and Applied Neurobiology. ,vol. 37, pp. 464- 483 ,(2011) , 10.1111/J.1365-2990.2011.01177.X